<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">

News & Events

Latest News

Keep up to date with the latest news from Crown Bioscience.

JSR Life Sciences Enters Definitive Agreement to Transfer Crown Bioscience to Adicon Holdings Limited

November 13, 2025

Crown Bioscience Achieves Second CLIA Certification of 2025 at Suzhou Laboratory

October 30, 2025

Crown Bioscience Named Best Preclinical Oncology CRO in the Healthcare and Pharmaceutical Awards 2025

October 16, 2025

Crown Bioscience Expands US Presence with New Model
Development Center in Kannapolis, North Carolina

September 17, 2025

Medicines Discovery Catapult and Crown Bioscience Form Strategic Global Alliance for Radiopharmaceutical Innovation

September 11, 2025

Crown Bioscience San Diego Achieves CLIA Certification to Enhance Clinical Trial Support

July 22, 2025

Crown Bioscience Announces Promotion of Alex Slater to Chief Business Officer, Signaling Continued Focus on Commercial Excellence

July 8, 2025

Crown Bioscience Named Fierce CRO Award Winner for Excellence in Global Operations

June 24, 2025

Crown Bioscience Achieves Green Lab Sustainability Certification

May 7, 2025

Crown Bioscience and NEXT Oncology Cement Partnership Extension

May 1, 2025

AACR 2025: Crown Bioscience Unveils 3D Bone Marrow Niche In Vitro Models for Oncology Preclinical Screening in Hematological Malignancies

April 28, 2025

Crown Bioscience Appoints John Gu as Chief Executive Officer

March 13, 2025

Crown Bioscience Completes Merger with Indivumed Services

February 17, 2025

Crown Bioscience Germany GmbH Achieves Continued CAP ISO 15189:2022 Accreditation

February 11, 2025

Crown Bioscience Wins 2024 Fierce CRO Award for Excellence in Client Service and Partnership

December 11, 2024

Crown Bioscience Wins BioTech Breakthrough Award for Drug Development Innovation

December 10, 2024

Prostate Cancer Breakthrough: Crown Bioscience Collaborates in €1.75M Eurostars Funded Project for Novel Liquid Biopsy Test

October 30, 2024

Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities

October 1, 2024

Crown Bioscience Partners with CTI to Support Consulting Services in Oncology Drug Development

August 21, 2024

Crown Bioscience Enters Global Agreement with Shanghai Model Organisms Center

May 24, 2024

Innovation Funding and Crown Bioscience: Collaborating to Discover the Next Wave of Oncology Therapies

May 23, 2024

Crown Bioscience Achieves CAP 15189 Accreditation; ISO 15189 Standard for Quality Medical Laboratory Services

April 11, 2024

Crown Bioscience Announces New Preclinical and Translational
Oncology Data Across Ten Poster Presentations at AACR 2024

March 28, 2024

Crown Bioscience Recognized Once Again as T+ Employer® for the Third Year in a Row

March 19, 2024

Crown Bioscience's Global Oncology Research Facilities Achieve Prestigious ISO and CAP Accreditations

January 23, 2024

Crown Bioscience Introduces OrganoidXplore: Revolutionizing Cancer Research with Rapid Large-scale Organoid Drug Screening

November 7, 2023

Indivumed Services’ Hamburg Site Receives College of American Pathologists (CAP) Accreditation

September 11, 2023

Crown Bioscience's Hamburg Site Receives College of American Pathologists (CAP) Accreditation

September 11, 2023

Crown Bioscience Enables HanX Biopharmaceutical to Progress HX009 to Clinical Trials

August 22, 2023

Crown Bioscience Announces Transaction Closing of Indivumed’s Service Business and Supporting Biobank

April 4, 2023

Crown Bioscience opens Singapore Laboratory and Establishes Local Commercial Partner

March 9, 2023

Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank

January 25, 2023

Crown Bioscience Publishes New Study in PLOS ONE Highlighting the Use of Clinically Relevant 3D In Vitro PDX-Derived Organoid Models as Powerful Tools to Accelerate Cancer Drug Discovery

January 5, 2023

Crown Bioscience and ERS Genomics Announce Global CRISPR/Cas9 Licensing Agreement for Genome Editing Patents

December 8, 2022

New Crown Bioscience Publication Details Application of In Vitro 3D Organoids with Matched PDX for Clinically Relevant Oncology Drug Development

December 1, 2022

Crown Bioscience & MBL launch joint venture to serve Japanese biopharmaceutical community

September 29, 2022

Crown Bioscience Appoints Michael Prosser as Chief Business Officer and Illustrates Further Investment in Commercial Leadership

July 28, 2022

First Clinical Candidate Developed using HUB Organoids® and High Content Screening Targets Cancer Stem Cells in Solid Tumors, Published in Nature Cancer

April 28, 2022

Crown Bioscience Expands UK Facilities to Enable Growth of In Vivo Services

December 8, 2021

Crown Bioscience Unveils New Identity

November 3, 2021

Crown Bioscience Launches ‘3D Ex Vivo Patient Tissue Platform’ to Improve Response Predictability to Immuno-Oncology Drug Candidates

October 7, 2021

Crown Bioscience Invests in Commercial Leadership

July 20, 2021

Crown Bioscience Announces Expedited Access to Well-Established ATCC and NIH Cell Lines for Large-Scale Screening Panels

June 3, 2021

Crown Bioscience Acquires OcellO B.V. to Expand Its Preclinical In Vitro Drug Development Service Offerings

May 5, 2021

Crown Bioscience and JSR Life Sciences Partner with Cambridge Quantum Computing to Leverage Quantum Machine Learning for Novel Cancer Treatment Biomarker Discovery

February 24, 2021

Crown Bioscience Expands Genomics and Next Generation Sequencing (NGS) Capabilities To Streamline Translational Biomarker Discovery Workflows

January 7, 2021

Crown Bioscience Increases APAC Capacity with New Facility in Zhongshan, China

October 27, 2020

Crown Bioscience Invests in Process Excellence with the Appointment of New Vice President of Global Quality

October 8, 2020

Crown Bioscience Signals Increased Investment in Digital Transformation with Appointment of New COO


August 6, 2020

Crown Bioscience Hosts Innovative Virtual AACR 2020 Conference and Tradeshow

June 18, 2020

New NAFLD/NASH Preclinical Model Data to be Presented at ADA 2020

June 9, 2020

Pivotal Preclinical Oncology Platform Expands to Include New Patient-Derived Organoid Models

May 26, 2020

Crown Bioscience Announces C-Suite Leadership Changes

April 14, 2020

Crown Bioscience Expands PDX Collection with Acquisition of Unique Models from Leading Academic Medical Centers

April 2, 2020

Two New Liver Fibrosis Rodent Models Launched by Crown Bioscience

March 10, 2020

Crown Bioscience and NEXT Oncology Announce Strategic PDX Model Partnership

October 28, 2019

Patient-Derived Tumor Organoid Drug Development Platform Launched

October 17, 2019

Crown Bioscience Announces Four New Preclinical NASH Models In Development

June 12, 2019

Crown Bioscience Announces San Diego, CA Site Expansion

May 9, 2019

Crown Bioscience and Hubrecht Organoid Technology Announce a Strategic Partnership, including Exclusive License to Provide Oncology Organoid-Based Preclinical Drug Development and Validation Services

March 27, 2019

Crown Bioscience to Present Latest Advancements in Preclinical and Translational Platforms at AACR Annual Meeting 2019

March 21, 2019

Crown Bioscience Inc. and Charles River Laboratories Enter Agreement to Expand Access to ZDSD Rat Model

March 15, 2019

Crown Bioscience Hosts 5th Annual Preclinical Oncology Drug Discovery Symposium

March 7, 2019

Crown Bioscience and The Jackson Laboratory Collaboration Enables Global Access to FATZO Mouse Model

March 1, 2019

Crown Bioscience Creates Center of Excellence for Bioinformatics, Big Data, and Biomarker Discovery Services

December 18, 2018

New Pancreatic Ductal Adenocarcinoma Research Published in Journal of Visualized Experiments

November 15, 2018

Crown Bioscience to Showcase Scientific Expertise at the EORTC-NCI-AACR

November 6, 2018

Crown Bioscience Releases MuBase® 2.0. An Open Access Database of Immuno-Oncology Murine Models

October 25, 2018

Crown Bioscience Completes Validation of Prostate Cancer Patient-Derived Xenograft (PDX) Models

September 26, 2018

Crown Bioscience Licenses Translational Breast Cancer Models of Resistance and Metastasis

September 18, 2018

CARsgen Therapeutics and Crown Bioscience complete CAR-T study for gastric cancer

September 13, 2018

CrownBio Expands Genetically Engineered Model Selection Via Strategic Alliance with Shanghai Model Organisms Center (SMOC)

August 14, 2018

Crown Bioscience Expands Novel Humanized Models for Targeted Immunotherapy Development to San Diego, CA Research Center

July 27, 2018

CrownBio Supports Excellence in Translational Research with Grant Award that Funds Innovative PDX Model Development in Immuno-Oncology

July 19, 2018

Crown Bioscience Enters Partnership with Pierre Fabre to Accelerate Discovery and Development of Immuno-Oncology Agents

June 19, 2018

Laurie Heilmann Named President of New Crown Bioscience Global Life Science and Diagnostic Solutions Division

June 6, 2018

CrownBio Demonstrates Advantages of Innovative Translational Oncology Platform in Scientific Posters at AACR 2018 Meeting

May 10, 2018

Crown Bioscience Launches New Humanized Target Model for Immunotherapy

April 26, 2018

CrownBio to Showcase Scientific Expertise in Preclinical Drug Development at the American Association for Cancer Research (AACR) Conference

April 4, 2018

Glycotope Selects Crown Bioscience as a Preclinical Development Partner to Advance Their Immunotherapeutic Pipeline

March 28, 2018

CBT Pharmaceuticals to Grow Immuno-Oncology Pipeline by License Agreement of CrownBio CTLA-4 Antibody

March 22, 2018

CrownBio Enters Strategic Partnership with Phanes Therapeutics to Accelerate Discovery and Development of Phanes’ Novel Oncology Agents

March 13, 2018

Crown Bioscience to Showcase Scientific Expertise at Cambridge UK Symposium: Preclinical Evaluation of Novel Immunotherapies

March 9, 2018

Webinar to Reveal Data Supporting the Use of MuScreen™ for Preclinical Immunotherapeutic Development

February 27, 2018

CAR T-Cell Therapy Platform

February 20, 2018

Enhanced MuScreen™ Platform Revolutionizes Preclinical Development of Immunotherapeutics

February 9, 2018

Crown Bioscience Resolutions from our 2018 The First Extraordinary General Meeting

February 8, 2018

Data on Novel Humanized Models for Targeted Immunotherapy Development

January 23, 2018

Innovative Humanized Research Strategies for Immuno-Oncology Drug Development Crown Bioscience Hosts a Live Webinar

January 17, 2018

Crown Bioscience Launches CrownSyn™, an Innovative Bioinformatics Solution that Simplifies the Characterization of Two-Drug Combination Studies

January 9, 2018

Crown Bioscience Announces Merger with JSR Corporation

December 21, 2017

Crown Bioscience International announces Agreement and Plan of Merger with JSR Corporation

December 20, 2017

Press Conference: 12.19.2017

December 19, 2017

Crown Bioscience Releases Scientific Posters Detailing Innovations in Preclinical Cancer Pharmacology

December 7, 2017

Crown Bioscience and Data Sciences International (DSI) Partner to Advance Metabolic Disease Research Using an Implanted Telemetry Device for Long-Term Blood Glucose Monitoring

November 27, 2017

Crown Bioscience’s Translatable FATZO Model Utilized in Eli Lilly’s Preclinical Type 2 Diabetes Research Programs

November 21, 2017

CrownBio Launches an Innovative Grant Program to Fund Advancements in Preclinical Oncology Research

November 17, 2017

Crown Bioscience Inc. Announcing the 2017 Board of Directors Election Results Dr. Guoliang Yu re-elected as the Chairman

November 9, 2017

Novel Preclinical Research Tools Provide Humanized Immune Response to Advance Immunotherapeutic Development, Live Webinar Hosted by Crown Bioscience

October 19, 2017

Crown Bioscience to Showcase Scientific Expertise in Preclinical Evaluation of Investigational Cancer Compounds at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference

October 17, 2017

Crown Bioscience Enhances Its European Capabilities with New Generation of Innovative Translational Models for Obesity and Diabetes

October 10, 2017

Crown Bioscience Names Laurie Heilmann Chief Business Officer Executive Leader Brings Expertise in Global Strategy and Commercial Leadership to the Role

September 27, 2017

Crown Bioscience’s Integrated Oncology Platform Helps Advance Apogenix’s Promising HERA-GITRL Immunotherapy for NSCLC and Head and Neck Cancer

September 13, 2017

Crown Bioscience Names Dr. Leon Hall Vice President of Global Scientific Excellence

August 22, 2017

Crown Bioscience Announces Second Quarter Results, Appoints Dr. Yangzhou Wang as Sr. VP of Global Operations

August 14, 2017

CrownBio Launches Innovative Inflammatory Disease Models to Advance Preclinical Research

July 27, 2017

Crown Bioscience expands its Life Science portfolio

July 13, 2017

CrownBio Demonstrates Scientific Advancements in Metabolic Disease with a validated and improved translatable model for obesity and Type 2 Diabetes drug discovery

July 6, 2017

The Jackson Laboratory and Crown Bioscience Announce Global Pre-Clinical Research Agreement

June 20, 2017

Crown Bioscience Announces Record Breaking Growth With First 2017 Quarter Results

May 19, 2017

Crown Bioscience Announces Collaboration to Develop Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Antibody

May 5, 2017

Crown Bioscience to Showcase Scientific Expertise and Data Digital Platform at American Association for Cancer Research

March 29, 2017

Crown Bioscience Launches e-Commerce Platform to Commercialize its Life Science Products

March 23, 2017

Crown Bioscience San Diego Center of Excellence Announces New General Manager

March 16, 2017

Crown Bioscience Enables Secure Data Real time Access with the Release of Client Facing Portal

March 9, 2017

Crown Bioscience Enhances Digital Connectivity with the Release of OncoExpress™ Technology Platform.

February 16, 2017

Crown Bioscience Announces Expansion of Life Science Division

January 26, 2017

Crown Bioscience Announces Expansion of Therapeutic Expertise into Inflammation

January 23, 2017

Crown Bioscience Expands US Capacity for Cardiovascular & Metabolic Disease Research Partners with New Iberia Research Center of Louisiana

January 12, 2017

Crown Bioscience Announces Further Enhancement of its Technology Platform with New MuBase® Models and Features

October 13, 2016

Crown Bioscience Introduces New In Vivo Platforms for Renal Research

October 4, 2016

Crown Bioscience Launches New Interactive Feature for XenoBase® In Vitro Models

September 22, 2016

Crown Bioscience Develops Innovative NAFLD Model

September 15, 2016

Crown Bioscience Launches New Translational Platforms For Metabolic Disease at Munich Diabetes Conference

September 6, 2016

Crown Bioscience Expands CVMD Leadership Team

August 25, 2016

Crown Bioscience Center of Excellence for Oncology in San Diego Expands Services

August 18, 2016

Crown Bioscience Announces the Completion of Over 100 Blood Cancer Studies

August 2, 2016

Crown Bioscience Expands US Operations, Establishes Center of Excellence for Oncology in San Diego

July 21, 2016

Crown Bioscience Announces Launch of OmniScreen Cell Panel Screening Platform

July 8, 2016

Crown Bioscience Introduces New Recombinant Cell Lines for Oncology Drug Discovery

June 30, 2016

Crown Bioscience Launching OncoExpress Technology at American Society of Clinical Oncology Meeting

May 24, 2016

Crown Bioscience Launches HuScreen a New High Throughput Service Platform Utilizing the Largest Available Collection of PDX Models

May 19, 2016

Crown Bioscience Announces the Establishment of Unique EGFR-mutated Non-Small Cell Lung Cancer Models

May 10, 2016

Crown Bioscience Launches MuScreen Platform for Evaluating In Vivo Efficacy of Immuno-oncology Agents

April 26, 2016

Crown Bioscience to Showcase Scientific Expertise at American Association of Cancer Research

April 12, 2016

Crown Bioscience Strengthens Immuno-oncology Capabilities With HuGEMM™

April 5, 2016

Crown Bioscience Licenses its HuBase™ PDX Management Software

March 29, 2016

Crown Bioscience Acquires PreClinOmics, Expands Cardiovascular and Metabolic Disease Portfolio

March 8, 2016

Crown Bioscience to Commercialize University of York’s Prostate Cancer Models for Drug Development

February 11, 2016

Crown Bioscience to Hold Symposium on Precision Medicine and Translating Oncology Drug Discovery into Success in the Clinic

January 28, 2016

Crown Bioscience Names Global Scientific Director for Translational Oncology

January 13, 2016

Crown Bioscience Announces Establishment of NASH Monitoring With its Translational Models

December 16, 2015

Crown Bioscience Expands Capacity in Europe and Invests in New Service Platforms

December 3, 2015

Crown Bioscience Offers Unique Immuno-Oncology Translational Research Platform

November 18, 2015

Crown Bioscience Is Largest Commercial Provider of Small Cell Lung Cancer PDX Models

November 3, 2015

Crown Bioscience to Host Pre-Show Symposium on Translational Oncology in Boston

October 28, 2015

Crown Bioscience Hires Two Industry Veterans for Expansion in Asia-Pacific Region

October 20, 2015

Crown Bioscience Expands Cardiovascular and Metabolic Disease Capabilities, Names New Scientific Director

October 14, 2015

Crown Bioscience Expands Services in Europe

October 8, 2015

Crown Bioscience Brings Top Scientists Together to Discuss Best Approaches to Advance Translational Oncology

September 30, 2015

Crown Expands Its Presence in France with Severine Marrony, Ph.D.

September 24, 2015

Crown Bioscience Expands Life Science Product Offering with Recombinant Cell Lines

June 22, 2015

Crown Bioscience Reveals Strategy for Combining Drug Therapy with Irradiation to Overcome Resistance to Oncology Therapeutics

June 19, 2015

Crown Bioscience Launches Life Science Product Catalog

March 3, 2015

Crown Bioscience Acquires Molecular Response’s Patient Derived Xenograft (PDX) Business

February 12, 2015

Crown Bioscience Announces a Key Expansion of its Partnership with The National Resource Center for Mutant Mice (NRCMM) on Developing Novel Immuno-oncology Mouse Models

February 4, 2015

Crown Bioscience Strengthens Pre-Clinical Leadership Team with Senior Appointment

January 30, 2015

Crown Bioscience Announces First European Symposium on Translational Oncology and the use of Patient-Derived Xenograft Models for Oncology Drug Discovery and Human Surrogate Trials

January 15, 2015

Crown Bioscience Expands Operations and Re-Brands UK Site

January 8, 2015

Crown Bioscience expands in the U.S. with new Translational Oncology Center.

October 20, 2014

Crown Bioscience Announces Inaugural Symposium to Foster Greater Understanding of Predictive Models in Oncology

August 14, 2014

Crown Bioscience President Dr. Jean-Pierre Wery Honored in PharmaVOICE 100

August 2, 2014

Crown Bioscience to showcase progression in human surrogate trials at the 50th ASCO Annual Meeting

May 20, 2014

Crown Bioscience receives $26.55 million in Series D Funding

May 15, 2014

Crown Bioscience Announces Research Collaboration with the National Resource Center for Mutant Mice (NRCMM)

May 8, 2014

Crown Bioscience Enters Japanese Market via Strategic Partnership with Shin Nippon Biomedical Laboratories

April 24, 2014

Crown Bioscience Passes 1000 Model Mark in PDX Collection for Oncology Drug Discovery

April 22, 2014

Crown Bioscience to Showcase Novel “in life” Platforms for Oncology and Metabolic Disease Drug Discovery at the AACR Annual Meeting 2014

February 14, 2014

Shanghai Institute of Materia Medica and Crown Bioscience Reach Landmark Agreement to Develop World-leading Mouse Clinical Center and Largest Annotated PDX and Translational Oncology Platform

November 26, 2013

Crown Bioscience Enhances Oncology Research Services with Targeted Beam Radiation Therapy via Business Collaboration with Xstrahl Ltd

October 14, 2013

Crown Bioscience Strengthens Oncology Expertise with Acquisition of PRECOS Ltd

July 30, 2013

Crown Bioscience, Inc. and Horizon Discovery Announce Exclusive Two Year Agreement to Offer Combined Solutions for In Vivo Drug Discovery Model Development

April 3, 2013

Crown Bioscience, Inc. and Horizon Discovery, Ltd. to Showcase X-MAN Cell Lines for In Vivo and In Vitro Drug Discovery Model Validation at EORTC-NCI-AACR Symposium

November 6, 2012

Crown Bioscience, Inc. Enters into Strategic Partnership with Jiangsu Hengrui Medicine Co., Ltd. for the Discovery and Commercialization of Novel Therapeutic Monoclonal Antibodies

January 11, 2012

Crown Bioscience Expands Distribution Network – Appoints On Target Co, Ltd. as Sales Representative in Japan to Enable Access to Translational Oncology Assets

August 11, 2011

Crown Bioscience, Inc. Announces Closing of Series C Financing

May 4, 2011

Allostem Therapeutics Teams with Crown Biosciences for Phase 0 Oncology Model Selection to Accelerate MEK Inhibitor Program

April 1, 2011

Crown Biosciences Announces Partnership With Jasco Pharmaceuticals to Develop Oncology Programs

December 7, 2010

Crown Bioscience Introduces New Informational Site Feature

July 12, 2010

Crown Bioscience Adds Former Distinguished Eli Lilly Scholar to its Senior Management Team

March 1, 2010